NCT04888559已完成不适用
Effects of a Whole Grain Cereal Product on Blood Glucose Response After 3 Consecutive Meals
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Aventure AB
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- The difference in capillary blood glucose between whole grain product and reference in the total incremental area under the curve iAUC(0-120 min) for all three meals (Breakfast iAUC0-120 min + Lunch iAUC0-120 min.+ Dinner iAUC0-120 min).
研究概览
简要总结
In this pilot study it will be investigated if a whole grain product will improve the glucose response not only when it is eaten at breakfast, but also at the two following meals; lunch and dinner (2nd and 3rd meal effect) in a healthy population.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Prevention
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 35 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Male or Female, 35 to 65 years of age
- •BMI 22-29 (±0.5) kg/m2
- •Agree to maintain consistent dietary habits and physical activity levels for the duration of the study.
- •Healthy as determined by medical history and information provided by the volunteer.
- •Willingness to complete questionnaires and follow instructions associated with the study and to complete all visits.
- •Has given voluntary, written, informed consent to participate in the study.
排除标准
- •Elevated fasting blood glucose (above 6.1 mmol/L at fasting on visit 1 or 2)
- •Women who are pregnant or breast feeding
- •Any medical condition(s) or medication(s) known to significantly affect glucose metabolism. Significance to be assessed by the QI
- •Use of medication, over-the-counter medication, natural health products or dietary supplements/probiotics that may affect glucose metabolism is prohibited during this study. Significance to be assessed by the QI. Participants who are taking allowed prescribed medications must agree to maintain their current method and dosing regimen during the course of the study unless other is recommended by their physician.
- •Known Type I or Type II diabetes, including women who previously have had gestational diabetes.
- •Use of antibiotics within 2 weeks of enrollment
- •Metabolic diseases and/or chronic gastrointestinal diseases (IBS, Crohns etc.)
- •Allergy to ingredients included in investigational product, placebo, or standardized meal
- •Participants restricted to a vegetarian or vegan diet
- •Intolerance to gluten
- •Individuals who are averse to capillary blood sampling
- •Currently active smokers (or using other tobacco products, and e-cigarettes)
- •Unstable medical conditions as determined by QI
- •Participation in other clinical research trials
- •Individuals who are cognitively impaired and/or who are unable to give informed consent
- •Acute infection
- •Any other condition which in the QI's opinion may adversely affect the individual's ability to complete the study or its measures or which may pose significant risk to the individual
结局指标
主要结局
The difference in capillary blood glucose between whole grain product and reference in the total incremental area under the curve iAUC(0-120 min) for all three meals (Breakfast iAUC0-120 min + Lunch iAUC0-120 min.+ Dinner iAUC0-120 min).
时间窗: Outcome measures will be assessed just before and immediately after the intervention (glucose measurements at 0-180 min after breakfast (intervention products), 0-180 min after lunch (standardized meal) and 0-120 min after dinner (standardized meal))
次要结局
- The difference in capillary blood glucose between whole grain product and reference in the 1, 2 and 3-hour incremental area under the curve (iAUC0-60 min, iAUC0-120 min and iAUC0-180 min) after the lunch meal.(Outcome measures will be assessed just before and immediately after the intervention (glucose measurements at 0-180 min after breakfast (intervention products) and 0-180 min after lunch (standardized meal)))
- The difference in capillary blood glucose between whole grain product and reference in the 1, 2 and 3-hour incremental area under the curve (iAUC0-60 min, iAUC0-120 min and iAUC0-180 min) after the breakfast meal.(Outcome measures will be assessed just before and immediately after the intervention (glucose measurements at 0-180 min after breakfast (intervention products))
- The difference in capillary blood glucose between whole grain product and reference in 2-hour Tmax(0-120 min) (the time to maximum concentration) after the breakfast, lunch and dinner meals respectively.(Outcome measures will be assessed just before and immediately after the intervention (glucose measurements at 0-180 min after breakfast (intervention products), 0-180 min after lunch (standardized meal) and 0-120 min after dinner (standardized meal)))
- The difference in capillary blood glucose between whole grain product and reference in 2-hour Cmax(0-120 min) (maximum concentration) after the breakfast, lunch and dinner meals respectively.(Outcome measures will be assessed just before and immediately after the intervention (glucose measurements at 0-180 min after breakfast (intervention products), 0-180 min after lunch (standardized meal) and 0-120 min after dinner (standardized meal)))
- The difference in capillary blood glucose between whole grain product and reference in the 1 and 2-hour incremental area under the curve (iAUC0-60 min and iAUC0-120 min) after the dinner meal.(Outcome measures will be assessed just before and immediately after the intervention (glucose measurements at 0-180 min after breakfast (intervention products), 0-180 min after lunch (standardized meal) and 0-120 min after dinner (standardized meal)))
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Glycaemic Response TestingGlycaemic IndexGlycaemic ResponseNCT01536847Mondelēz International, Inc.12
已完成
不适用
Glycemic Response TestingGlycemic IndexGlycemic ResponseNCT01536860Mondelēz International, Inc.12
已完成
早期 1 期
Glycemic Response of Whole Beans and Bean ProductsHealthyBody Mass Index, NormalPostprandial HyperglycemiaNCT06630312Iowa State University21
招募中
不适用
Food Product for Management of Gestational DiabetesGestational DiabetesGlucose Tolerance Impaired in PregnancyGlucose Tolerance ImpairedPregnancy RelatedInsulin Sensitivity/ResistanceNCT05917808Stoffwechselzentrum Rhein - Pfalz25
已完成
不适用
A Study to Evaluate Glucose and Insulin Response to NutralinDiabetesNCT01275820Avera McKennan Hospital & University Health Center10